Abstract:Osteoporosis is a pathological condition characterized by an accelerated bone resorption rate, resulting in decreased bone density and increased susceptibility to fractures, particularly among the elderly population. While conventional treatments for osteoporosis have shown efficacy, they are associated with certain limitations, including limited drug bioavailability, non-specific administration, and the occurrence of adverse effects. In recent years, nanoparticle-based drug delivery systems have emerged as a promising approach for managing osteoporosis. Nanoparticles possess unique physicochemical properties, such as a small size, large surface area-to-volume ratio, and tunable surface characteristics, which enable them to overcome the limitations of conventional therapies. These nanoparticles offer several advantages, including enhanced drug stability, controlled release kinetics, targeted bone tissue delivery, and improved drug bioavailability. This comprehensive review aims to provide insights into the recent advancements in nanoparticle-based therapy for osteoporosis. It elucidates the various types of nanoparticles employed in this context, including silica, polymeric, solid lipid, and metallic nanoparticles, along with their specific processing techniques and inherent properties that render them suitable as potential drug carriers for osteoporosis treatment. Furthermore, this review discusses the challenges and future suggestions associated with the development and translation of nanoparticle drug delivery systems for clinical use. These challenges encompass issues such as scalability, safety assessment, and regulatory considerations. However, despite these challenges, the utilization of nanoparticle-based drug delivery systems holds immense promise in revolutionizing the field of osteoporosis management by enabling more effective and targeted therapies, ultimately leading to improved patient outcomes.

Drug delivery for age-related bone diseases: From therapeutic targets to common and emerging therapeutic strategies

Drug Delivery Based on Nanotechnology for Target Bone Disease.

Research and Application of Target Therapy for Osteoporosis

Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease

Bone targeted nano-drug and nano-delivery

Advance in Drug Delivery for Ageing Skeletal Muscle

Advances in Nanotherapy for Targeting Senescent Cells

Nanoscale Materials-Based Platforms for the Treatment of Bone-Related Diseases

Emerging nano-scale delivery systems for the treatment of osteoporosis

Nanoparticle-Based Drug Delivery Systems for Enhancing Bone Regeneration

Drug Delivery and Therapy Strategies for Osteoporosis Intervention

Targeted Delivery of Anti-Osteoporosis Therapy: Bisphosphonate-modified Nanosystems and Composites

Anti-aging properties of phytoconstituents and phyto-nanoemulsions and their application in managing aging-related diseases

The application of nanomaterials in controlled drug delivery for bone regeneration

The advances in nanomedicine for bone and cartilage repair

Microenvironment-responsive nanocarriers for targeted bone disease therapy

Recent advances in bone-targeting nanoparticles for biomedical applications

Targeting Mitophagy As a Potential Therapeutic Approach for Age‐Related Bone Diseases

Biomaterial design for regenerating aged bone: materiobiological advances and paradigmatic shifts

Nanotechnology Controlled Drug Delivery for Treating Bone Diseases.

Nanomaterial-based drug delivery of immunomodulatory factors for bone and cartilage tissue engineering